SynthesisFrontiers in oncology2022

Efficacy and safety of CD22-specific and CD19/CD22-bispecific CAR-T cell therapy in patients with hematologic malignancies: A systematic review and meta-analysis.

Lili Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.